Clinical trial
Sitagliptin Added-on to Insulin Study (0431-051)
NCT00395343
Study timeline
Study start (actual)2006-12-11Date precision: day
Registry last updated2017-05-12
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Type 2 Diabetes Mellitusunresolved
Interventions
sitagliptin phosphateDRUG · verified · RxNorm: sitagliptin phosphate
Sponsors & collaborators
Merck Sharp & Dohme LLClead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00395343 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.